drugset / Trial / NCT00004489
Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
Treatment
Summary
OBJECTIVES: I. Determine the bioavailability and biologic effect of alendronate on bone metabolism in patients with cystic fibrosis. II. Assess the safety and efficacy of this treatment regimen in improving osteoporosis in this patient population.
Timeline
- Start
- 1998-10
- Primary completion
- —
- Completion
- 2002-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alendronic Acid | Small molecule | — | Oral |
| Background | Calcium carbonate | Other / unclassified | — | — |
| Background | Cholecalciferol | Other / unclassified | — | — |